欢迎访问ProbeChem中文网站,英文网站请访问www.probechem.com

首页-抗体药物偶连体和PROTACs-PROTAC-INNO-220
INNO-220

Chemical Structure : INNO-220

CAS No.: 3032577-24-2

INNO-220 (INNO220)

货号: PC-24767Not For Human Use, Lab Use Only.

INNO-220 is a highly selective and potent, CRBN-dependent, orally bioavailable degrader of CK1α without affecting IKZF1/3, impairs cell viability and selectively degraded CK1α in lymphoma cells.

规格 价格 库存 数量
25 mg Get quote
50 mg Get quote
100 mg Get quote

大包装,大折扣!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

纯度 & COA & 质检文件 纯度: >98% (HPLC)

生物&药学活性

INNO-220 is a highly selective and potent, CRBN-dependent, orally bioavailable degrader of CK1α without affecting IKZF1/3, impairs cell viability and selectively degraded CK1α in lymphoma cells.
INNO-220 inhibits cells harboring wild-type p53 and exhibiting constitutive NF-κB signaling.
INNO-220 inhibits IL-2 expression by disrupting the CBM complex and inhibiting NF-κB activity.
INNO-220 suppresses NF-κB signaling and activates p53 pathway, leading to complete inhibition of lymphoma tumor growth in vivo.
INNO-220 disrupts the assembly and function of the CARD11/BCL10/MALT1 complex, thereby inhibiting NF-κB signaling in stimulated T cells and lymphoma cells that harbor an activating mutation in CARD11.

物理化学性质&存储条件

分子量 400.44
分子式 C23H20N4O3
外观性状 Solid
CAS No.
储存条件
固体粉末
-20°C 12 个月; 4°C 6 个月
配置液
-80°C 6 个月; -20°C 6 个月
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

3-(5-(1-Methyl-5-phenyl-1H-pyrazol-4-yl)-1-oxoisoindolin-2-yl)piperidine-2,6-dione

参考文献

1. Feng S, et al. Leukemia. 2025 May 27. doi: 10.1038/s41375-025-02647-x.

2. Patent WO2024054832 A1.

备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

联系我们 sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

询单

  • *产品名称:
  • *姓名:
  • *邮箱:
  • *公司名称:
  • *询单数量:
  • *国籍:
  • 询单信息: